ctrl K

Price Alert

Mirum Pharmaceuticals Inc... (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

67.89

3.06 (4.72%)

At close: Aug 15, 2025, 3:59 PM

67.86

-0.04%

After-hours: Aug 15, 2025, 06:59 PM EDT

Mirum Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	222.5M	286.33M	28M	31.34M
Short-Term Investments	57.81M	n/a	123.72M	125.2M
Long-Term Investments	12.53M	n/a	100M	4.98M
Other Long-Term Assets	5.81M	4.17M	101.38M	101.79M
Receivables	78.29M	67.97M	23.99M	3.27M
Inventory	22.4M	22.31M	5.57M	1.51M
Other Current Assets	11.78M	10.94M	8.95M	5.27M
Total Current Assets	392.79M	387.54M	190.22M	166.59M
Property-Plant & Equipment	9.81M	1.99M	2.35M	2.55M
Goodwill & Intangibles	249.82M	252.93M	58.95M	18.74M
Total Long-Term Assets	277.97M	259.08M	162.68M	128.06M
Total Assets	670.75M	646.62M	352.91M	294.65M
Account Payables	14.62M	7.42M	8.69M	9.17M
Deferred Revenue	n/a	n/a	n/a	30.72M
Short-Term Debt	n/a	n/a	931K	711K
Other Current Liabilities	102.57M	57.6M	37.06M	21.41M
Total Current Liabilities	126.55M	87.06M	64.73M	42.6M
Long-Term Debt	308.08M	306.42M	1.26M	1.9M
Other Long-Term Liabilities	2.51M	3.85M	143.63M	128.04M
Total Long-Term Liabilities	318.56M	310.89M	146.14M	131.84M
Total Liabilities	445.11M	397.95M	210.87M	174.44M
Total Debt	317.76M	308.14M	2.19M	2.61M
Common Stock	5K	5K	4K	3K
Retained Earnings	-644.18M	-556.24M	-392.82M	-257.16M
Comprehensive Income	-373K	1.64M	-217K	-35K
Shareholders Equity	225.64M	248.67M	-392.82M	120.21M
Total Investments	70.34M	n/a	123.72M	130.18M